MQS Management LLC Takes $471,000 Position in Prestige Consumer Healthcare Inc. $PBH

MQS Management LLC bought a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 5,901 shares of the company’s stock, valued at approximately $471,000.

Several other institutional investors also recently modified their holdings of the business. Keeler Thomas Management LLC bought a new position in shares of Prestige Consumer Healthcare in the second quarter valued at approximately $1,079,000. AlphaQuest LLC grew its holdings in Prestige Consumer Healthcare by 1,432.8% during the second quarter. AlphaQuest LLC now owns 3,786 shares of the company’s stock valued at $302,000 after purchasing an additional 3,539 shares during the period. Ground Swell Capital LLC bought a new position in Prestige Consumer Healthcare during the second quarter valued at $239,000. Caitong International Asset Management Co. Ltd grew its holdings in Prestige Consumer Healthcare by 312.5% during the second quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company’s stock valued at $26,000 after purchasing an additional 250 shares during the period. Finally, Tributary Capital Management LLC bought a new position in Prestige Consumer Healthcare during the second quarter valued at $11,773,000. 99.95% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

PBH has been the subject of several research reports. Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price objective for the company in a report on Wednesday, September 24th. Wall Street Zen lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Zacks Research lowered Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a report on Thursday, September 4th. Weiss Ratings reissued a “hold (c)” rating on shares of Prestige Consumer Healthcare in a report on Saturday. Finally, Oppenheimer reduced their price objective on Prestige Consumer Healthcare from $82.00 to $72.00 and set an “outperform” rating for the company in a report on Tuesday, October 21st. Four equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $90.60.

Prestige Consumer Healthcare Trading Down 0.5%

Shares of PBH stock opened at $62.27 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. Prestige Consumer Healthcare Inc. has a 52-week low of $60.15 and a 52-week high of $90.04. The company has a market capitalization of $3.06 billion, a PE ratio of 14.62, a price-to-earnings-growth ratio of 1.97 and a beta of 0.44. The business’s fifty day moving average is $64.06 and its 200 day moving average is $74.64.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm had revenue of $249.53 million for the quarter, compared to analysts’ expectations of $260.71 million. During the same quarter in the previous year, the business earned $0.90 EPS. The company’s revenue for the quarter was down 6.6% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. On average, equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.